Kenvue Reports Full Year and Fourth Quarter 2023 Results : v

FY’23: Net Sales Increased 3.3% to $15.4 billion with Organic Growth1 of 5.0%


FY’23: Diluted Earnings per Share of $0.90; Adjusted Diluted Earnings per Share1 of $1.29


Q4’23: Net Sales...

Related Keywords

China , United States , Russia , America , Johnson , Asia Pacific , Paul Ruh , Thibaut Mongon , New York Stock Exchange , Company Net , Women Health , Kenvue Inc , Company Cash , Us Skin Health , Skin Health , Exchange Commission , York Stock Exchange , Chief Executive , Fourth Quarter , Chief Financial , Brand Adhesive Bandages , Deferred Markets , Private Securities Litigation Reform Act , Quarterly Reports , Consolidated Statement , Millions Except Per Share Data , Three Months Ended December , Net Sales , Three Months Ended January , Twelve Months Ended December , Twelve Months Ended January , Year Organic Growth , Oral Care , Gum Therapy , Segment Net Sales , Adjusted Operating , Care Adjusted , Beauty Adjusted , Health Adjusted , Geographic Region , Middle East , Markets ,